Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Amyloidosis × venetoclax × Clear all

Status

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Primary Myelofibrosis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Amyloidosis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03123029 2026-01-30

Expanded Access to Venetoclax

AbbVie

LymphoidOther hematologic neoplasmPlasma cell

Amyloidosis, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡